There are 5 papers on CK2 in aging research: none in people yet, 1 in animals, 3 in cells, 1 review.
At a glance
The findings reach cells, none yet in people. 2 independent labs in 2 countries.
None of its findings points the other way.
- 2 independent labs in 2 countries
- Funders: National Research Foundation of Korea and 3 more
- Model organisms1
- Cells3
Interventions
2Quercetin
downin reviews1
1 study
Quercetin
downin reviews1
Quercetin inhibits CK2 (high nanomolar concentrations).
“certain flavonols, notably quercetin, can inhibit CK2 in high nanomolar concentrations that may be clinically relevant”
Reviewhigh nanomolar concentrations
International journal of molecular sciences
Spermidine
upin mouse cells1
1 study
Spermidine
upin mouse cells1
Spermidine activates CK2 in mouse cells.
“Permidine treatment activates CK2 by releasing the interaction between lamin A and CK2”
Cellspermidine
Lamin A buffers CK2 kinase activity to modulate aging in a progeria mouse model
Science advances
Effects
3RelA/p65 K310 acetylation
downin human cells1
1 study
RelA/p65 K310 acetylation
downin human cells1
CK2 decreases RelA/p65 K310 acetylation in human cells (shown by knockdown).
“increased the acetylation of lysine 310 on RelA/p65”
Cellsshown by knockdown
International journal of molecular sciences
Senescence-associated secretory phenotype (SASP)
downin human cells1
1 study
Senescence-associated secretory phenotype (SASP)
downin human cells1
CK2 decreases senescence-associated secretory phenotype (SASP) in human cells (shown by knockdown in MCF-7 and HCT116 cells).
“CK2 down-regulation induced the expression of SASP factors, including interleukin (IL)-1β, IL-6, and matrix metalloproteinase (MMP) 3”
Cellsshown by knockdown in MCF-7 and HCT116 cells
International journal of molecular sciences
SIRT1PROTEIN
downin human cells1
1 study
SIRT1PROTEIN
downin human cells1
CK2 decreases SIRT1PROTEIN in human cells (CK2 downregulation).
“CK2 downregulation destabilized SIRT1 protein via an ubiquitin-proteasome pathway in human cells”
CellsCK2 downregulation
BMB reports